Bidirectional Regulation Of Novelty-induced Behavioral Inhibition By The Endocannabinoid System

Attention Deficit Disorder (ADD) and Attention Deficit Hyperactivity Disorder (ADHD)

Key Findings

“These data show a tightly regulated influence of the ECS on impulsive behaviors and suggest the involvement of endocannabinoid signaling in the pathophysiological modulation of ADHD and related disorders.”

Information and Links


Link: Bidirectional Regulation Of Novelty-induced Behavioral Inhibition By The Endocannabinoid System

Year: 2009

DOI: 10.1016/j.neuropharm.2009.07.014


Ratings

(How Ratings Work)

Attention Deficit Disorder (ADD) and Attention Deficit Hyperactivity Disorder (ADHD) — 2


Possible to probable range of efficacy of cannabis for treatment of Attention Deficit Disorder (ADD) and Attention Deficit Hyperactivity Disorder (ADHD) according to the results found in this study.

Drugs Used

Fatty acid amide hydrolase (FAAH) inhibitor URB597 (increases anandamide), CB1 receptor inverse agonist AM251, HU210